Your browser doesn't support javascript.
loading
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503).
Morris, Michael J; Mota, Jose Mauricio; Lacuna, Kristine; Hilden, Patrick; Gleave, Martin; Carducci, Michael A; Saad, Fred; Cohn, Erica D; Filipenko, Julie; Heller, Glenn; Shore, Neal; Armstrong, Andrew J; Scher, Howard I.
Afiliação
  • Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: morrism@mskcc.org.
  • Mota JM; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lacuna K; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Hilden P; Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gleave M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Carducci MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
  • Saad F; Division of Urology, University of Montreal Hospital Center (CHUM), Montreal, QC, Canada.
  • Cohn ED; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Filipenko J; Prostate Cancer Clinical Trials Consortium, New York, NY, USA.
  • Heller G; Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Shore N; Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA.
  • Armstrong AJ; Divisions of Medical Oncology and Urology, Departments of Medicine and Surgery at the Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University School of Medicine, Durham, NC, USA.
  • Scher HI; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Eur Urol Oncol ; 4(4): 543-552, 2021 08.
Article em En | MEDLINE | ID: mdl-34020931

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article